Position in XGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$506,817
-$359,658 QoQ
Shares Held
108,993
-62.3% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 57 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $771,534,982 across 27 Diagnostics & Research names. XGN ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
315,164 | $165,914,936 | |
| 2 | DHR |
Danaher Corp /De/
|
702,933 | $133,894,677 | |
| 3 | NTRA |
Natera, Inc.
|
336,268 | $91,279,948 | |
| 4 | GH |
Guardant Health, Inc.
|
580,133 | $87,037,353 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
167,029 | $83,741,659 | |
| 6 | LH |
Labcorp Holdings Inc.
|
258,438 | $72,362,640 | |
| 7 | A |
Agilent Technologies, Inc.
|
466,294 | $61,937,832 | |
| 8 | DGX |
Quest Diagnostics Inc
|
117,831 | $24,974,280 |
All Filings in XGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $506,817 | 108,993 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $866,475 | 288,825 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $535,234 | 88,032 | Shares | Defined | 2026-02-13 | |
| 2020-12-31 | $133,029 | 10,078 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $193,515 | 17,852 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $171,940 | 13,855 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $257,797 | 16,173 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||